The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Brief ReportFull Access

Racial Effects on Neuropsychological Functioning in Schizophrenia

Abstract

OBJECTIVE: This study assessed the effects of race on neuropsychological functioning in patients with schizophrenia. METHOD: A total of 160 patients with schizophrenia completed an extensive neuropsychological test battery. Scores were standardized to a group of 99 psychiatrically and physically healthy subjects and categorized into seven functional domains: concentration, executive function, language, motor function, spatial memory, verbal memory, and visual processing. RESULTS: African Americans (N=25) had significantly lower mean scores on executive function, language, spatial memory, and visual processing than did Caucasians (N=135). Statistical control for patient and family education eliminated all significant effects. CONCLUSIONS: Educational differences in patients and families may account for some of the performance heterogeneity reported in patients with schizophrenia and should be routinely analyzed with other sociodemographic factors such as race and sex.

Despite the efforts of the National Institutes of Health to facilitate the systematic study of potential racial effects in patients with schizophrenia, there is still little we know about the relationship between race and biobehavioral measures (1). Racial differences in neuropsychological functioning are expected to be found on the basis of results from nonclinical samples (25). As we indicated in an earlier article (1), the majority of studies of schizophrenia fail to mention the racial composition of their study groups; some studies “control” for race, and a minority report racial effects that are inconsistent. The importance of reporting such differences inheres in possible racial differences in etiology and therapeutic strategies. The first step, however, is a rigorous assessment of whether such differences exist.

We took the opportunity to examine racial differences in a large (N=160) study of neuropsychological functioning in schizophrenia patients that was originally designed to assess sex differences (69). There are many complex conceptual and methodological issues regarding the relationships among race, ethnicity, social class, and culture that we will not address in this analysis, as it was not designed with those issues in mind. The study we conducted is, however, typical of neuropsychological studies of schizophrenia and provides a stepping stone for other, more comprehensive analyses. The first goal was to report simple racial differences in neuropsychological functioning. Neuropsychological functioning is known to correlate significantly with educational attainment (10). It was important, therefore, to control for years of education (1113). We did this statistically for both patients and the patients’ families of origin.

Method

Descriptions of patient recruitment and clinical assessment, neuropsychological testing, and methods of data reduction have been published elsewhere (6, 7). All procedures and materials were approved by our institution’s human investigations committee. Procedures were fully explained, and all patients provided written informed consent before participating in the study. We studied 160 (135 Caucasian and 25 African American) patients who met the DSM-III-R criteria for schizophrenia or schizoaffective disorder and for whom we had neuropsychological test results and information about family education. Neuropsychological test scores were categorized into seven functional domains: concentration, executive function, language, motor function, spatial memory, verbal memory, and visual processing. Scores in these functional domains were standardized relative to a healthy comparison group.

We measured education in years completed for both patients and patients’ families. When this information was available for both of the patients’ parents, only the higher number of years of education was used in the analyses. We conducted two sets of analyses: a one-way (racial) analysis of variance on each of the neuropsychological domain scores and a one-way (racial) analysis of covariance (ANCOVA), using patient and family education as covariants.

Results

There were no significant differences in the percentage of men, mean age, or mean age at first hospital admission between the two racial groups. The Caucasian schizophrenia patients had a significantly higher mean number of years of education than did the African American patients (F=5.21, df=1, 155, p=0.02). This was also true for their parents (F=12.69, df=1, 158, p<0.0001).

Table 1 reveals that mean standardized neuropsychological domain scores were higher in the Caucasian group than in the African American group. Both groups had scores that fell significantly below those of the healthy comparison subjects, which was reflected in scores below 0, the mean score of the healthy comparison group. The racial effect was greatest on language (F=11.96, df=1, 121, p=0.001), followed by visual processing (F=8.64, df=1, 117, p=0.004), spatial memory (F=7.72, df=1, 140, p=0.006), and executive function (F=4.21, df=1, 137, p=0.04). Racial effects on concentration, motor function, and verbal memory were not statistically significant.

ANCOVAs controlling for patient and family education eliminated all statistically significant racial effects. Patient education effect sizes were larger than family education effect sizes for verbal memory (0.05 versus 0.01) and visual processing (0.06 versus 0.03). Family education yielded larger effect sizes than patient education on concentration (0.06 versus 0.05), executive function (0.02 versus 0.01), language (0.14 versus 0.11), motor function (0.07 versus 0.04), and spatial memory (0.11 versus 0.04). Pearson’s correlation coefficients between neuropsychological scores and patient and family education were all statistically significant at the 0.05 level. Coefficients ranged from 0.19 (executive function and patient education) to 0.48 (language and family education). Separate analysis by race yielded comparable results.

Discussion

To our knowledge, our study is one of few to report the results of the analysis of racial effects in schizophrenia (1). We believe this study is unique in the literature in that it examines the effects of the education of the family of origin on the neuropsychological functioning of patients with schizophrenia. It is of interest that family education had a larger effect than patient education on most domains of neuropsychological functioning.

In this study, all racial (African American and Caucasian) differences in neuropsychological functioning among schizophrenia patients were explained by education. Much of the covariance was carried by the educational level of the family of origin, suggesting that the results did not simply reflect an artifact of control for highly correlated patient characteristics.

Socioeconomic status, reflected in part by educational attainment, is a potentially powerful moderator of behavioral measures, particularly of neuropsychological function (12, 13). It is reasonable to expect that the variability of social class of origin may contribute to the within-group performance variability that so frequently characterizes schizophrenia.

TABLE 1

Received Sept. 28, 1999; revision received May 16, 2000; accepted May 17, 2000. From the Skyland Trail Health and Education Center and the Department of Psychiatry and Behavioral Sciences, School of Medicine, Emory University. Address reprint requests to Dr. Lewine, Skyland Trail Health and Education Center, 1903 N. Druid Hills, Atlanta, GA 30319; (e-mail). Supported by NIMH grant MH-44151.

References

1. Lewine R, Caudle J: At issue: race in the “decade of the brain.” Schizophr Bull 1999; 25:1–5Crossref, MedlineGoogle Scholar

2. Bernard LC: Halstead-Reitan neuropsychological test performance of black, Hispanic, and white young adult males from poor academic backgrounds. Arch Clin Neuropsychol 1999; 4:267–274CrossrefGoogle Scholar

3. Brown A, Campbell A, Wood D, Hastings A, Lewis JO, Dennis G, Ford-Booker P, Hicks L, Adeshoye A, Weir R: Neuropsychological studies of blacks with cerebrovascular disorders: a preliminary investigation. J Natl Med Assoc 1991; 83:217–224MedlineGoogle Scholar

4. Lichtenberg PA, Ross T, Christensen B: Preliminary normative data on the Boston Naming Test for an older urban population. Clin Neuropsychol 1994; 8:109–111CrossrefGoogle Scholar

5. Penk WE, Brown AS, Roberts WR, Dolan MP, Atkins HG, Robinowitz R: Visual memory of black and white male heroin and nonheroin drug users. J Abnorm Psychol 1981; 90:486–489Crossref, MedlineGoogle Scholar

6. Lewine R, Haden C, Caudle J, Shurett R: Sex-onset effects on neuropsychological function in schizophrenia. Schizophr Bull 1997; 23:57–61CrossrefGoogle Scholar

7. Lewine RRJ, Walker EF, Shurett R, Caudle J, Haden C: Sex differences in neuropsychological functioning among schizophrenic patients. Am J Psychiatry 1996; 153:1178–1184Google Scholar

8. Gueguerian R, Lewine R: Brain torque and sex differences in schizophrenia. Schizophr Res 1998; 30:175–181Crossref, MedlineGoogle Scholar

9. Purcell D, Lewine R, Caudle J, Price L: Sex differences in verbal IQ—performance IQ discrepancies in patients with schizophrenia and normal controls. J Abnorm Psychol 1998; 107:161–165Crossref, MedlineGoogle Scholar

10. Lezak M: Neuropsychological Assessment, 2nd ed. New York, Oxford University Press, 1993Google Scholar

11. Albus M, Hubmann W, Mohr F, Scherer J, Sobizack N, Franz U, Hecht S, Borrmann M, Wahlheim C: Are there gender differences in neuropsychological performance in patients with first-episode schizophrenia? Schizophr Res 1997; 28:39–50Google Scholar

12. Kremen WS, Seidman LJ, Faraone SV, Pepple JR, Lyons MJ, Tsuang MT: The “3Rs” and neuropsychological function in schizophrenia: an empirical test of the matching fallacy. Neuropsychology 1996; 10:22–31CrossrefGoogle Scholar

13. Blanchard J, Neale J: Medication effects: conceptual and methodological issues in schizophrenia research. Clin Psychol Rev 1992; 12:345–361CrossrefGoogle Scholar